Should You Sell Morphosys Ag (MOR) Stock Thursday Morning?

Morphosys Ag (MOR) has risen Thursday morning, with the stock gaining 1.27% in pre-market trading to 4.79. MOR's short-term technical score of 13 indicates that the stock has traded less bullishly over the last month than 87% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, MOR ranks higher than 18% of stocks. Morphosys Ag has risen 0.21% over the past month, closing at $4.70 on August 25. During this period of time, the stock fell as low as $4.14 and as high as $5.29. MOR has an average analyst recommendation of Sell. The company has an average price target of $7.70.

MOR has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on MOR!

See Full MOR Report

Morphosys Ag has a Long-Term Technical rank of 28. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 72% of the market scoring higher. In the Biotechnology industry which is number 54 by this metric, MOR ranks better than 54% of stocks.

Important Dates for Investors in MOR:

-Morphosys Ag is set to release earnings on 11/9/2022. Over the last 12 months, the company has reported EPS of $-0.54. -We do not have a set dividend date for Morphosys Ag at this time. Click Here To Get The Full Report on Morphosys Ag (MOR)